STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Natera, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed by Natera insider indicates planned sale of 19,908 shares of common stock with an aggregate market value of $3,335,585.40. The sale is scheduled for June 18, 2025, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.

The securities were originally acquired as Restricted Stock Units from the issuer on September 21, 2020. The seller, Daniel Rabinowitz, has conducted three previous sales in the past 3 months totaling 3,867 shares with gross proceeds of $566,033.98:

  • April 28, 2025: 1,993 shares for $303,299.52
  • April 21, 2025: 470 shares for $68,407.52
  • March 31, 2025: 1,404 shares for $194,326.94

The company currently has 136,546,580 shares outstanding. This proposed sale represents approximately 0.015% of total shares outstanding.

Positive

  • None.

Negative

  • CFO Daniel Rabinowitz plans to sell 19,908 shares worth approximately $3.34M, following recent sales of 3,867 shares over the past 3 months totaling $566K

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many NTRA shares are being sold according to the Form 144 filing from June 2025?

According to the Form 144 filing, 19,908 shares of NTRA common stock are proposed to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,335,585.40.

What was the total value of NTRA shares sold by Daniel Rabinowitz in the past 3 months before the Form 144 filing?

In the three months prior to the filing, Daniel Rabinowitz sold a total of 3,867 NTRA shares in three separate transactions, generating gross proceeds of $566,033.98. The sales occurred on 04/28/2025 (1,993 shares), 04/21/2025 (470 shares), and 03/31/2025 (1,404 shares).

How did the seller originally acquire the NTRA shares being sold?

The 19,908 NTRA shares were originally acquired on 09/21/2020 through Restricted Stock Units (RSUs) granted by the issuer (Natera, Inc.).

What is NTRA's total shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, Natera, Inc. (NTRA) had 136,546,580 shares outstanding at the time of the filing.

When is the approximate date of sale for the NTRA shares listed in the June 2025 Form 144?

The Form 144 filing indicates that the approximate date of sale for the 19,908 NTRA shares is 06/18/2025 on the NASDAQ exchange.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

32.64B
133.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN